While all services below will prescribe Mounjaro to people ... The FDA has sent warning letters to companies selling compounded tirzepatide and semaglutide. Eli Lilly has also raised safety ...

But today marks the first official agency warning about ... after you start Mounjaro and for 4 weeks after each increase in your dose of Mounjaro.” A spokesperson for Eli Lilly, the maker ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

INDIANAPOLIS — Eli Lilly filed lawsuits against compounding pharmacies and an Indianapolis weight loss company over the use of Zepbound and Mounjaro. On April 1, 2025, Lilly filed lawsuits against two ...

INDIANAPOLIS — Eli Lilly filed lawsuits against compounding pharmacies and an Indianapolis weight loss company over the use of Zepbound and Mounjaro. On April 1, 2025, Lilly filed lawsuits against two ...

File photo of bariatric surgeon Amar Vennapusa, administering a dose of Eli Lilly's Mounjaro, to his patient P Keerthi Reddy, 32, at his health clinic in Hyderabad in April 2025. (Reuters / Almaas ...

Eli Lilly's growth is impressive, driven by Mounjaro and Zepbound, but its current valuation is only justifiable with sustained high growth. Despite strong results and superior products ...

Sales of Eli Lilly’s (NYSE:LLY) Mounjaro in India rose 60% in May from April, the first full month the popular weight loss/diabetes drug was available in the country following its commercial ...

Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its popular weight-loss and diabetes treatments, Zepbound and Mounjaro.

Eli Lilly (NYSE ... drugs to help people lose weight. Right now, Lilly sells tirzepatide, commercialized as Mounjaro for type 2 diabetes and as Zepbound for weight loss, though doctors have ...